CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Madrigal Pharmaceuticals, Inc. - MDGL CFD

286.99
2.88%
  • Summary
  • Historical Data
Trading сonditions
Spread 0.72
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.02629 %
Charges from full value of position ($-5.00)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.02629%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.004068 %
Charges from full value of position ($0.77)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.004068%
Overnight fee time 21:00 (UTC)
Min traded quantity 0.45
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 278.96
Open 279.74
1-Year Change 27.58%
Day's Range 279.74 - 294.94
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jul 19, 2024 286.99 7.25 2.59% 279.74 297.14 276.55
Jul 18, 2024 278.96 11.13 4.16% 267.83 283.80 267.51
Jul 17, 2024 269.21 -0.51 -0.19% 269.72 283.25 264.83
Jul 16, 2024 273.23 -6.57 -2.35% 279.80 285.69 273.22
Jul 15, 2024 279.47 -6.35 -2.22% 285.82 287.32 275.98
Jul 12, 2024 285.44 -4.72 -1.63% 290.16 297.36 279.91
Jul 11, 2024 289.82 5.00 1.76% 284.82 292.83 279.85
Jul 10, 2024 283.64 -8.62 -2.95% 292.26 292.89 282.85
Jul 9, 2024 292.41 6.19 2.16% 286.22 294.90 286.21
Jul 8, 2024 290.09 11.76 4.23% 278.33 291.79 276.44
Jul 5, 2024 276.38 5.55 2.05% 270.83 278.05 268.63
Jul 3, 2024 266.83 -5.69 -2.09% 272.52 272.91 266.83
Jul 2, 2024 271.51 -4.52 -1.64% 276.03 281.83 271.09
Jul 1, 2024 279.05 2.27 0.82% 276.78 281.83 276.12
Jun 28, 2024 279.20 -4.63 -1.63% 283.83 284.89 277.22
Jun 27, 2024 285.09 12.89 4.74% 272.20 287.79 269.83
Jun 26, 2024 274.86 -1.97 -0.71% 276.83 278.83 267.51
Jun 25, 2024 279.60 -0.49 -0.17% 280.09 284.82 278.23
Jun 24, 2024 283.49 6.77 2.45% 276.72 286.73 273.56
Jun 21, 2024 277.79 12.72 4.80% 265.07 280.42 264.91

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Madrigal Pharmaceuticals, Inc. Company profile

About Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. The Company’s lead product candidate, MGL-3196 (resmetirom), is a liver-directed, selective thyroid hormone receptor-ß (THR-ß) agonist for the treatment of non-alcoholic steatohepatitis (NASH)and heterozygous familial hypercholesterolemia (HeFH). Its product pipeline also includes MGL-3745, which is used in the treatment of NASH and HeFH.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Madrigal Pharmaceuticals Inc revenues was not reported. Net loss increased 20% to $241.8M. Higher net loss reflects R & D increase of 11% to $194.5M (expense), G & A increase from $10M to $21.1M (expense), Stock-based Compensation in SGA increase of 36% to $16.2M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -$13.09 to -$14.63.

Equity composition

Common Stock $.0001 Par, 10/10, 100M auth., 42,166,779 issd. Insiders control approx. 37.8%. IPO: 2/06/07, 5M shares @ $10 per share by Bear, Stearns & Co. Inc.

Industry: Bio Therapeutic Drugs

200 Barr Harbor Dr Ste 400
WEST CONSHOHOCKEN
PENNSYLVANIA 19428-2978
US

People also watch

Gold

2,401.36 Price
-1.830% 1D Chg, %
Long position overnight fee -0.0198%
Short position overnight fee 0.0116%
Overnight fee time 21:00 (UTC)
Spread 1.20

ETH/USD

3,513.71 Price
-0.430% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

BTC/USD

67,537.80 Price
+0.050% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

US100

19,526.60 Price
-1.140% 1D Chg, %
Long position overnight fee -0.0263%
Short position overnight fee 0.0041%
Overnight fee time 21:00 (UTC)
Spread 7.0

Still looking for a broker you can trust?

Join the 630,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading